Natera (NTRA) Cash from Investing Activities Growth (1y) (2015 - 2026)
Natera (NTRA) Cash from Investing Activities Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.62 Bn | 208.56 Bn | 8.34 Bn | 156.94% |
| 2 | Danaher | 139.22 Bn | 134.87 Bn | 3.61 Bn | -3,832.95% |
| 3 | Idexx Laboratories | 46.07 Bn | 45.88 Bn | 779.09 Mn | 24.18% |
| 4 | Agilent Technologies | 39.35 Bn | 37.54 Bn | 990.00 Mn | 32.46% |
| 5 | Iqvia Holdings | 38.18 Bn | 36.10 Bn | 1.44 Bn | -10.12% |
| 6 | Natera | 37.68 Bn | 36.58 Bn | 696.04 Mn | -91.12% |
| 7 | Illumina | 28.60 Bn | 27.43 Bn | 770.00 Mn | -148.98% |
| 8 | Mettler Toledo International | 28.37 Bn | 28.32 Bn | 650.22 Mn | 95.92% |
| 9 | Quest Diagnostics | 26.30 Bn | 25.67 Bn | 1.03 Bn | -8.06% |
| 10 | Labcorp Holdings | 25.82 Bn | 24.84 Bn | 1.01 Bn | 4.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.12% |
| Dec 31, 2025 | -543.93% |
| Sep 30, 2025 | -146.79% |
| Jun 30, 2025 | 25.45% |
| Mar 31, 2025 | -112.16% |
| Dec 31, 2024 | -146.05% |
| Sep 30, 2024 | -47.67% |
| Jun 30, 2024 | -167.92% |
| Mar 31, 2024 | 771.17% |
| Dec 31, 2023 | 10.17% |
| Sep 30, 2023 | 22.06% |
| Jun 30, 2023 | 35.65% |
| Mar 31, 2023 | -92.33% |
| Dec 31, 2022 | -72.43% |
| Sep 30, 2022 | 115.44% |
| Jun 30, 2022 | -41.99% |
| Mar 31, 2022 | 138.68% |
| Dec 31, 2021 | 180.17% |
| Sep 30, 2021 | -290.98% |
| Jun 30, 2021 | 136.25% |